Correlating Cicatricial Alopecia and Cardiovascular Risk: Emerging Insights

    Andrea Sechi, Antonellá Tosti
    The study "Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease" by Kim et al. (2023) explores the link between Primary Cicatricial Alopecia (PCA) and cardiovascular disease (CVD) risk, involving over 400,000 individuals from the National Health Insurance Service registry. The findings indicate that patients with PCA have an 18% increased likelihood of developing CVDs compared to controls, with specific subtypes like lichen planopilaris (LPP) showing a pronounced risk. The study suggests that chronic inflammatory diseases, such as PCA, are associated with endothelial dysfunction and increased CV risk. However, the study did not adjust for alopecia severity or exclude androgenetic alopecia, which could confound results. Despite these limitations, the research highlights a potential systemic aspect of PCA, warranting further investigation into its role in CVD risk.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 271 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 2 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 6 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  121 upvotes 4 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Similar Research

    6 / 1000+ results